Does vitamin D reduce seizures?

There is no reliable evidence that it does. The established reason to attend to vitamin D in epilepsy is bone protection in people taking enzyme-inducing anticonvulsants.

Why do epilepsy drugs lower vitamin D?

Phenytoin, carbamazepine, phenobarbital and primidone induce liver enzymes that convert vitamin D to inactive metabolites, so levels fall at any given intake.

How much vitamin D should I take on anticonvulsants?

Often more than the general population, commonly 1,000-4,000 IU daily, but the dose should follow a 25-hydroxyvitamin D test and your clinician's advice.

Is vitamin D safe with my epilepsy medication?

Yes, supplementation is generally safe alongside anticonvulsants. It should be added to treatment, never used as a reason to reduce medication.

Do newer epilepsy drugs affect vitamin D?

Levetiracetam and lamotrigine are not strong enzyme inducers and are much less associated with this problem, so standard adult intake is usually adequate.

Condition

Moderate Evidence

Effectiveness 3/5

Vitamin D for Epilepsy

Enzyme-inducing anti-seizure drugs accelerate vitamin D breakdown and reduce bone density. Monitoring and repletion is standard care, not an optional extra.

Overview

Vitamin D matters in epilepsy for a reason most people do not expect. The strongest case is not seizure control but bone protection, because several long-standing antiepileptic drugs accelerate the breakdown of vitamin D and are associated with lower bone density and more fractures.

People taking enzyme-inducing anticonvulsants for years therefore sit in a well-documented risk group, and correcting vitamin D status is a low-cost, well-tolerated part of managing that risk alongside calcium intake and weight-bearing activity. Claims that vitamin D reduces seizure frequency are a separate question with far weaker support. Small open-label reports exist, but nothing in the evidence linked here establishes an anticonvulsant effect.

Never change epilepsy medication yourself

Vitamin D is an addition to treatment, never a substitute. Stopping or reducing an anticonvulsant without neurological supervision risks breakthrough seizures and status epilepticus.

How It Works

Phenytoin, carbamazepine, phenobarbital and primidone induce hepatic cytochrome P450 enzymes, including those that hydroxylate vitamin D into inactive metabolites. The result is faster clearance of 25-hydroxyvitamin D and lower circulating levels at any given intake.

Lower vitamin D reduces intestinal calcium absorption, which raises parathyroid hormone and increases bone turnover. Sustained over years, that pattern shows up as reduced bone mineral density and a higher fracture rate, compounded in epilepsy by injuries sustained during seizures. Because the mechanism is accelerated catabolism rather than poor absorption, people on these drugs often need more vitamin D than the general population to reach the same blood level.

Dosing & Protocol

Dosing should be guided by a 25-hydroxyvitamin D test and by which drug you take, since enzyme inducers raise requirements while newer agents such as levetiracetam and lamotrigine largely do not.

Context	Dose	Form	Timing
General adult maintenance	800-2,000 IU daily	Vitamin D3	Daily with food
On enzyme-inducing anticonvulsants	1,000-4,000 IU daily, clinician-guided	Vitamin D3	Daily, with level checks
Documented deficiency	Clinician-directed replacement	D3	Retest after 3 months
Bone support alongside	1,000-1,200 mg calcium daily, mainly from food	Diet first	Spread across the day

Ask which drug class you are on

The vitamin D issue is largely specific to enzyme-inducing anticonvulsants. If you are on levetiracetam or lamotrigine alone, standard adult intake is usually sufficient.

Evidence

The evidence linked to this pairing is a 2010 review in Annals of Pharmacotherapy examining antiepileptic drugs, vitamin D and bone health.

Studies linked to this pairing.

Antiepileptic drugs and bone health: vitamin D and fracture risk

Score: 7/10

2010

systematic_review

Lee RH, Lyles KW, Colon-Emeric C

Enzyme-inducing antiepileptic drugs increase vitamin D catabolism and are associated with reduced bone mineral density.

View source

It documents that enzyme-inducing antiepileptic drugs accelerate vitamin D catabolism and are associated with reduced bone mineral density and increased fracture risk. That establishes the rationale for monitoring and correcting vitamin D status in this population. It does not test whether supplementation reduces seizures, and the fracture data are largely observational. Read the verdict here as support for bone protection in people on these medicines, not as evidence for treating epilepsy itself.

Safety

Vitamin D3 at maintenance and replacement doses is well tolerated. Excessive sustained intake can cause hypercalcaemia, presenting as nausea, thirst, confusion and kidney stones - and confusion is a symptom that is particularly unhelpful to introduce in epilepsy care.

Report any change in seizure pattern

Any increase in seizure frequency, new aura or prolonged seizure needs urgent medical review, regardless of what supplements are being taken.

Anyone with sarcoidosis, hyperparathyroidism, kidney stones or chronic kidney disease should only supplement under supervision. Children on long-term anticonvulsants should have vitamin D and bone health managed by their paediatric team rather than through over-the-counter dosing.

Interactions & Conflicts

The central interaction in this pairing is the anticonvulsant itself. Beyond that, the usual vitamin D cautions around calcium-raising drugs apply.

Interacts with	Severity	Mechanism	Action
Phenytoin, carbamazepine, phenobarbital, primidone	moderate	Enzyme induction accelerates vitamin D catabolism	Expect higher requirement; monitor 25-OH levels
Corticosteroids	moderate	Further impair calcium absorption and bone density	Bone protection plan with your clinician
Thiazide diuretics	moderate	Reduced calcium excretion with increased absorption	Monitor serum calcium
Digoxin	moderate	Raised calcium increases toxicity risk	Medical supervision required

References

The citation below is the study currently linked to this pairing in our library.

Frequently Asked Questions

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.